Xeris Biopharma (XERS) Q4 2023 Earnings

6MarConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.15
-0.1
-0.05
0

Details

Expected EPS
-0.085491
Actual EPS
-0.1
Surprise EPS
-0.01
Surprise Percent
+16.97%

Description

Xeris Biopharma (XERS) has reported earnings of -0.1 per share for Q4 2023.

0 Comments

Share your thoughts